HighGravityDataMolina Healthcare — Oct 23, 2024 release
Fiscal 2024 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001179929-24-000148
Showing in the filing
GAAP Net income
“$ 1,250”
Period
FY2024
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 9
Premium revenue for FY2024
“approximately $38 billion”
Adjusted earnings for FY2024
“at least $23.50 per diluted share”
Adjusted net income Per Diluted Share for FY2024
“$ 23.50”
Adjusted EPS growth for FY2024
“approximately 13%”
GAAP Net income for FY2024
“$ 1,250”
GAAP Net income Per Diluted Share for FY2024
“$ 21.59”
Adjusted net income for FY2024
“$ 1,360”
Statutory tax rate (income tax effect) for FY2024
“approximately 25.5%”
Diluted weighted average shares outstanding … for FY2024
“approximately 57.9 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Reports Third Quarter 2024 Financial Results Page 11 October 23, 2024 MOLINA HEALTHCARE, INC. RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED) 2024 GUIDANCE Amount Per Diluted Share (2) GAAP Net income $ 1,250 $ 21.59 Adjustments: Amortization of intangible assets 83 1.43 Acquisition-related expenses 49 0.86 Other 16 0.27 Subtotal, adjustments 148 2.56 Income tax effect (1) (38) (0.65) Adjustments, net of tax 110 1.91 Adjusted net income $ 1,360 $ 23.50 __________________ (1) Income tax effect calculated at the statutory tax rate of approximately 25.5%. (2) Computations assume approximately 57.9 million diluted weighted average shares outstanding. -END-
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.